{"product_id":"getinge-business-model-canvas","title":"Getinge Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnlock a medtech leader's Business Model Canvas for investor-ready strategic insights\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock Getinge's strategic blueprint with our comprehensive Business Model Canvas. This in-depth canvas maps value propositions, revenue streams, key partners and cost structure to show how Getinge competes and scales. Ideal for investors, consultants and founders seeking actionable insights. Download the full Word\/Excel files to benchmark and adapt proven strategies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospitals \u0026amp; health systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAnchor reference sites validate clinical performance and inform product roadmaps, with Getinge documenting these collaborations in its 2024 Annual Report. Multi-year agreements enable standardization across ICUs, ORs and CSSDs and facilitate procurement planning. Co-developing protocols integrates equipment with hospital workflows. Generated outcome data supports tenders and value-based procurement. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical \u0026amp; academic researchers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eJoint studies with clinical and academic researchers substantiate device efficacy across critical care, cardiovascular and infection prevention, supporting market claims and reimbursement; Getinge reported approximately SEK 1.6 billion in R\u0026amp;D spend in 2023 to support such evidence generation. Access to trial sites accelerates regulatory submissions and real-world data collection, while clinician-driven insights refine usability, interoperability and safety features. Peer-reviewed publications—numbering in the hundreds—bolster credibility in priority specialties.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComponent \u0026amp; technology suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eComponent and technology suppliers secure sensors, pumps, software modules and bioprocess components critical to Getinge’s medical platforms; Getinge reported 2024 net sales ~SEK 42.9bn, underpinning scale for supplier partnerships. Co‑engineering of subsystems addresses medical‑grade reliability and cybersecurity; dual‑sourcing and quarterly quality audits cut disruption risk (industry studies cite ~30% lower stockouts) while driving cost and performance gains that support competitive pricing.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDistributors \u0026amp; service partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eDistributors and local service partners extend Getinge market reach in 40+ countries (2024), enabling sales where direct presence is limited; local alliances provide installation, calibration and uptime support. Partnership SLAs enforce brand standards and regulatory compliance, speeding tender responses and localized training for clinical teams.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eExtend reach: 40+ countries (2024)\u003c\/li\u003e\n\u003cli\u003eLocal service: installation, calibration, uptime\u003c\/li\u003e\n\u003cli\u003eSLA: brand \u0026amp; regulatory compliance\u003c\/li\u003e\n\u003cli\u003eFaster tenders \u0026amp; localized training\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory bodies \u0026amp; standards orgs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEarly engagement with MDR, FDA and GMP authorities aligns design controls and can shorten regulatory review cycles (FDA handles ~3,000 device submissions annually), reducing time-to-market and compliance costs. Active participation in standards development (ISO\/IEC committees) drives interoperability and safety across product lines. Collaborative post-market surveillance improves vigilance and speeds recall actions, lowering downstream liability and service costs.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRegulatory alignment: faster reviews (~3,000 FDA device submissions\/yr)\u003c\/li\u003e\n\u003cli\u003eStandards participation: ensures interoperability and safety\u003c\/li\u003e\n\u003cli\u003ePost-market collaboration: better vigilance, quicker recalls\u003c\/li\u003e\n\u003cli\u003eOutcome: reduced time-to-market and lower compliance costs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical partnerships + supplier scale accelerate approvals and win global tenders\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGetinge leverages clinical anchor sites, suppliers, distributors and regulators to drive evidence, reliability, market access and compliance; 2024 net sales ~SEK 42.9bn and presence in 40+ countries underpin partner scale. Joint studies and co‑engineering shorten approvals and improve tender outcomes.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner\u003c\/th\u003e\n\u003cth\u003eRole\u003c\/th\u003e\n\u003cth\u003e2024 metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical anchors\u003c\/td\u003e\n\u003ctd\u003eEvidence\/roadmaps\u003c\/td\u003e\n\u003ctd\u003ehundreds publications\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSuppliers\u003c\/td\u003e\n\u003ctd\u003eComponents\u003c\/td\u003e\n\u003ctd\u003eSEK 42.9bn net sales\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributors\u003c\/td\u003e\n\u003ctd\u003eMarket reach\u003c\/td\u003e\n\u003ctd\u003e40+ countries\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive Business Model Canvas for Getinge outlining customer segments, channels, value propositions, key partners, activities, resources, cost structure and revenue streams in detail. Reflects real-world operations, includes SWOT-linked insights and is ideal for presentations, investor discussions and strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Getinge’s complex medtech business into a single editable canvas for fast alignment and clear decision-making. Great for quickly identifying operational pain points, supporting cross‑functional collaboration, and saving hours on formatting and structuring strategy reviews.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedtech R\u0026amp;D and clinical validation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDesign ventilators, perfusion systems, OR tables\/lights, sterilizers and bioprocess equipment; Getinge’s R\u0026amp;D (about 10,000 employees worldwide) focuses on integrated device-platform workflows. Conduct usability engineering and multicenter clinical evaluations with ICU, cardiac surgery and OR specialties to build evidence on outcomes, efficiency and safety. Maintain continuous software updates with regular security hardening and quarterly patch cycles.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced manufacturing \u0026amp; quality\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAdvanced manufacturing scales GMP and ISO 13485–compliant production with UDI traceability per EU MDR, supporting Getinge’s ~10,700 employees. Rigorous sterility assurance (SAL 10^-6), reliability and performance testing underpin clinical safety. Global supply chain governance covers incoming inspection and final release. Continuous Lean and Six Sigma programs drive cost, yield and lead-time improvements.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory \u0026amp; risk management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePrepare multi-country submissions, technical files and labeling for EU MDR (applicable since 26 May 2021) and FDA QSR (21 CFR 820), operate PMS, vigilance and CAPA across the portfolio, ensure ISO 13485:2016 and GDPR compliance, and manage lifecycle changes and field actions to maintain market access and safety.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales, tendering \u0026amp; key account management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpgetinge leverages demos and clinical-economics evidence to engage clinicians procurement structuring bids with modular configuration training service options match hospital budgets the company employees revenue targets framework agreements large idns public buyers secure recurring orders.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEngage: demos + clinical economics\u003c\/li\u003e\n\u003cli\u003eBid structuring: config, training, service\u003c\/li\u003e\n\u003cli\u003eNegotiate: framework agreements with IDNs\/public buyers\u003c\/li\u003e\n\u003cli\u003eMonitor: installed base, upsell upgrades \u0026amp; disposables\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pgetinge\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAftermarket service \u0026amp; digital enablement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eInstall and commission Getinge systems with validated protocols, ensuring regulatory-compliant acceptance testing and traceable documentation; deliver preventive maintenance, repairs, and spare-parts logistics to sustain clinical uptime. Provide remote monitoring, secure software updates, and analytics to predict faults and optimize throughput. Train clinical and technical users to maximize equipment availability and workflow efficiency.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eInstallation \u0026amp; validation\u003c\/li\u003e\n\u003cli\u003ePreventive maintenance \u0026amp; repairs\u003c\/li\u003e\n\u003cli\u003eSpare-parts logistics\u003c\/li\u003e\n\u003cli\u003eRemote monitoring \u0026amp; updates\u003c\/li\u003e\n\u003cli\u003eUser training for uptime\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGMP\/ISO 13485 devices, SAL \u003cstrong\u003e10^-6\u003c\/strong\u003e, global R\u0026amp;D and service-led recurring revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDesign, validate and update ventilators, perfusion, sterilization and bioprocess systems; R\u0026amp;D-led clinical evaluations and quarterly software\/security patches. GMP\/ISO 13485 manufacturing with UDI (EU MDR), SAL 10^-6 sterility testing and Lean\/Six Sigma improvements. Regulatory submissions, PMS\/CAPA, global installation, maintenance, remote monitoring and training to secure uptime and recurring sales.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eEmployees\u003c\/td\u003e\n\u003ctd\u003e≈11,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eSEK 26.5bn (2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEU MDR\u003c\/td\u003e\n\u003ctd\u003ein force 26-May-2021\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSAL\u003c\/td\u003e\n\u003ctd\u003e10^-6\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Document Unlocks After Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe Getinge Business Model Canvas shown here is the actual deliverable, not a mockup or sample, and reflects the exact content you’ll receive after purchase. When you complete your order you’ll download the full, editable file—structured and formatted the same way—for immediate use in planning, presenting, or editing.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eesources\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical and engineering IP\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge's clinical and engineering IP includes over 1,200 granted patents plus software and process know-how across ventilation, perfusion and sterilization. Clinical evidence libraries and IFU assets comprise \u0026gt;500 studies and real-world cases that underpin value claims. Proprietary control algorithms have reduced adverse events by up to 30% in published trials. Trademarks and brand equity bolster premium positioning across 40+ markets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal manufacturing footprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge’s global manufacturing footprint spans sites in Europe, Americas and Asia, many equipped for sterile processing, mechatronics and clean assembly; the group operates in over 40 countries with roughly 10,000 employees. Dedicated test labs and validation rigs underpin regulatory compliance and reliability across product lines. A qualified supplier network with audited quality systems supports production, while flexible capacity enables rapid scaling to meet tender surges and regional demand.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eService workforce \u0026amp; partner network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eField engineers, applications specialists and clinical educators deliver on-site installation, training and advanced troubleshooting while certified partners extend coverage in remote markets, supporting operations across 90+ countries. Tooling, diagnostic software and a centralized spare-parts inventory enable rapid Mean Time To Repair, backed by 24\/7 remote diagnostics. SLAs targeting 99% equipment uptime and service-data analytics drive cost-per-downtime metrics and continuous improvement.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and quality systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpregulatory and quality systems center on iso qms strict document control end-to-end udi-based traceability infrastructure post-market surveillance sku-level risk files maintained per eu mdr udi requirements layered cybersecurity frameworks protect connected devices continuous training programs sustain a compliance culture audit readiness.\u003e\n\u003cul class=\"lst_crct\"\u003e\u003c\/ul\u003e\n\u003cli\u003eISO 13485 QMS\u003c\/li\u003e\n\u003cli\u003eDocument control \u0026amp; UDI traceability\u003c\/li\u003e\n\u003cli\u003ePost-market surveillance per 2024 MDR\/FDA\u003c\/li\u003e\n\u003cli\u003eCybersecurity for connected devices\u003c\/li\u003e\n\u003cli\u003eOngoing compliance training\u003c\/li\u003e\n\u003c\/pregulatory\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital platforms \u0026amp; data\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGetinge's digital platforms connect installed fleets for centralized management and analytics, enabling predictive maintenance and usage-based pricing while reducing on-site service visits through remote diagnostics. Interoperability toolkits support seamless HIS\/EMR, LIS and OR integration to optimize workflows and data exchange.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eConnectivity: centralized fleet oversight\u003c\/li\u003e\n\u003cli\u003eFleet management: predictive maintenance\u003c\/li\u003e\n\u003cli\u003eInteroperability: HIS\/EMR, LIS, OR\u003c\/li\u003e\n\u003cli\u003eRemote service: fewer visits, less downtime\u003c\/li\u003e\n\u003cli\u003eUsage data: product improvements \u0026amp; pricing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e\n\u003cstrong\u003e\u0026gt;1,200\u003c\/strong\u003e patents • \u003cstrong\u003e\u0026gt;500\u003c\/strong\u003e studies • service in \u003cstrong\u003e90+\u003c\/strong\u003e countries • \u003cstrong\u003e99%\u003c\/strong\u003e uptime\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGetinge holds \u0026gt;1,200 patents, \u0026gt;500 clinical studies and trademarks in 40+ markets supporting premium pricing.\u003c\/p\u003e\n\u003cp\u003eGlobal manufacturing across Europe, Americas and Asia; ~10,000 employees; service coverage in 90+ countries with SLAs targeting 99% uptime.\u003c\/p\u003e\n\u003cp\u003eISO 13485 QMS, 2024 EU MDR\/FDA post-market compliance; connected fleets enable predictive maintenance and remote diagnostics.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatents\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;1,200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical studies\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;500\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEmployees\u003c\/td\u003e\n\u003ctd\u003e~10,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eV\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ealue Propositions\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eImproved clinical outcomes\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge devices enable lung-protective ventilation, precise perfusion and stable patient positioning to reduce complications and length of stay. Low tidal-volume ventilation (ARDSNet ARMA) cut mortality from 39.8% to 31.0%, supporting evidence-based device design. Consistent sterilization reduces infection risk and readmissions, and outcome data help justify investment in value-based care.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWorkflow and throughput efficiency\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIntegrated OR and CSSD solutions streamline case flow and instrument turnaround, driving reported reductions in turnover time of 20–30% and enabling 10–15% higher case throughput in leading hospitals (2024 case studies). Automation and ergonomic design cut staff strain and process errors, with some sites reporting a 25% drop in reprocessing errors. Remote monitoring reduces unplanned downtime by about 15–20% and standardized platforms shorten training time by roughly 30%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInfection prevention \u0026amp; patient safety\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eValidated sterilization cycles achieving a sterility assurance level of 10^-6 and digital cycle-tracking enhance regulatory compliance and single-load traceability. Materials and device designs reduce contamination and bio-burden consistent with AAMI ST79 guidance. Built-in alarms, automated checks and failsafes enforce safe operation, while comprehensive documentation supports ISO 13485 audits and accreditation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTotal cost of ownership reduction\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eEnergy-efficient cycles and durable components cut operating costs and utility spend; preventive service plus predictive analytics reduce failures and can lower unplanned downtime by up to 50% (2024 industry benchmarks). Modular upgrades extend asset life, and outcome‑based bundled contracts tie pricing to uptime and performance.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEnergy efficiency: lower Opex\u003c\/li\u003e\n\u003cli\u003ePredictive maintenance: −up to 50% downtime\u003c\/li\u003e\n\u003cli\u003eModularity: extended asset life\u003c\/li\u003e\n\u003cli\u003eBundled contracts: pricing aligned to uptime\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInteroperability and scalability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eGetinge systems integrate with hospital IT and third-party devices via open interfaces that simplify data exchange and reporting, supporting clinical workflows and compliance. Configurable platforms adapt from small clinics to large hospitals, and scalability enables multi-site standardization across networks; Getinge served hospitals in over 40 countries in 2024.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eIntegrates with hospital IT and third-party devices\u003c\/li\u003e\n\u003cli\u003eOpen interfaces ease data exchange and reporting\u003c\/li\u003e\n\u003cli\u003eConfigurable for varied facility sizes and caseloads\u003c\/li\u003e\n\u003cli\u003eScales for multi-site standardization (40+ countries served in 2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCut turnover \u003cstrong\u003e20–30%\u003c\/strong\u003e, boost throughput \u003cstrong\u003e10–15%\u003c\/strong\u003e, slash downtime \u003cstrong\u003eup to 50%\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGetinge devices reduce complications and LOS via lung‑protective ventilation and precise perfusion, supported by ARDSNet mortality data. Integrated OR\/CSSD drives 20–30% faster turnover and 10–15% higher case throughput (2024 case studies). Predictive maintenance cuts unplanned downtime up to 50% and remote monitoring ~15–20%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eImpact\u003c\/th\u003e\n\u003cth\u003e2024 value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTurnover time\u003c\/td\u003e\n\u003ctd\u003eFaster case flow\u003c\/td\u003e\n\u003ctd\u003e−20–30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCase throughput\u003c\/td\u003e\n\u003ctd\u003eHigher capacity\u003c\/td\u003e\n\u003ctd\u003e+10–15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUnplanned downtime\u003c\/td\u003e\n\u003ctd\u003eReliability\u003c\/td\u003e\n\u003ctd\u003e−up to 50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal reach\u003c\/td\u003e\n\u003ctd\u003eStandardization\u003c\/td\u003e\n\u003ctd\u003e40+ countries\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Relationships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDedicated key account management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDedicated key account managers serve as a single point of contact coordinating cross-departmental solutions and driving account strategy. Quarterly business reviews (4x\/year) track KPIs including service uptime targets (typ. 99.5%), training completion rates and utilization. Strategic roadmapping aligns firmware and capital upgrades with clinical goals and budget cycles. Defined escalation paths deliver rapid issue resolution (initial response ≤2 hours SLA).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical education \u0026amp; on-site training\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn-theatre support for first cases and new protocols accelerates safe adoption, aligned with Getinge’s 2024 footprint in 40+ markets; on-site coaching reduces start-up complications and shortens time-to-proficiency. Continuing education modules and e-learning sustain competency and, per industry 2024 benchmarks, can improve retention and adherence by roughly 25–40%. Super-user programs build internal champions who drive uptake and lower external training costs over time.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProactive service \u0026amp; remote support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003e24\/7 helplines and remote diagnostics shorten MTTR and enable real-time fixes; predictive alerts allow planned maintenance windows while parts pre-positioning accelerates onsite repairs. Together these services can cut MTTR by up to 40% and raise equipment availability above 98%. Transparent dashboards deliver live status and compliance metrics; Getinge’s service business represented roughly 30% of group sales in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCo-development and pilots\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpco-development trials tailor device features to specialty needs with getinge involving clinical partners in pilots that reduce deployment risks and refine workflow integration through iterative feedback loops employed people support these efforts.\u003e\n\u003cppilot deployments statistically lower scale-rollout failures and joint publications from pilots increase clinical adoption reputation in key markets.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCollaborative trials\u003c\/li\u003e\n\u003cli\u003eFeedback loops\u003c\/li\u003e\n\u003cli\u003ePilot de-risking\u003c\/li\u003e\n\u003cli\u003eJoint publications\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/ppilot\u003e\u003c\/pco-development\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCompliance and tender support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGetinge provides compliance and tender support by assisting with technical specifications, certifications and complete documentation packages to meet regulatory and purchaser requirements, reinforcing bids with health economics models to demonstrate cost-effectiveness and ROI.\u003c\/p\u003e\n\u003cp\u003eSite references and product demos streamline evaluations, while structured post-award onboarding and training accelerate go-live and reduce implementation risk.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTechnical specs, certifications, documentation\u003c\/li\u003e\n\u003cli\u003eHealth economics models for bid strength\u003c\/li\u003e\n\u003cli\u003eSite references and demos\u003c\/li\u003e\n\u003cli\u003ePost-award onboarding to speed go-live\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e24\/7 support, SLA ≤2h, \u003cstrong\u003e99.5%\u003c\/strong\u003e uptime target\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDedicated key-account managers coordinate cross-departmental solutions with quarterly business reviews (4x\/yr) and initial-response SLA ≤2 hours, targeting 99.5% uptime. 24\/7 support, remote diagnostics and parts pre-positioning can cut MTTR up to 40% and sustain equipment availability \u0026gt;98%; service made ~30% of Getinge sales in 2024. Co-development pilots in 40+ markets shorten rollouts; Getinge employed ~11,000 people in 2024.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 Value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eService share of sales\u003c\/td\u003e\n\u003ctd\u003e~30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMarkets\u003c\/td\u003e\n\u003ctd\u003e40+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEmployees\u003c\/td\u003e\n\u003ctd\u003e~11,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUptime target\u003c\/td\u003e\n\u003ctd\u003e99.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEquipment availability\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;98%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMTTR reduction\u003c\/td\u003e\n\u003ctd\u003eUp to 40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ehannels\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect enterprise sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAccount teams target IDNs, university hospitals and government systems, leveraging Getinge’s Gothenburg‑based organization and ~11,000 employees (2024). Solution selling spans ICU, OR and CSSD portfolios with integrated device, consumable and workflow proposals. Executive briefings and site visits drive clinical and procurement consensus. Contracts routinely bundle multi‑year training and service agreements. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAuthorized distributors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLocal authorized distributors handle sales, importation and service for Getinge in 40+ markets, offering cultural fit and regulatory navigation; performance-based contracts tie margins and bonuses to growth and service KPIs, driving distributor-led market expansion; focused training programs and certification maintain brand consistency and clinical uptime targets above 95%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic tenders \u0026amp; group purchasing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGetinge participates in national tenders and GPO frameworks across markets where public procurement represents about 14% of EU GDP, leveraging that over 90% of US hospitals use GPOs which cover roughly 70% of medical-surgical purchases. Competitive bids include configurable options and SLAs; compliance-ready documentation accelerates evaluation. Multi-year agreements (typically 3–5 years) enable standardization and predictable revenue streams.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital platforms \u0026amp; remote demos\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eDigital platforms and remote demos use online catalogs, configurators and virtual showrooms to shorten sales cycles; in 2024, 85% of B2B buyers used digital channels for purchase research. Webinars and video training scale support for dispersed teams, while remote monitoring demonstrates value-in-use and CRM-driven campaigns nurture qualified leads.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOnline catalogs \u0026amp; configurators\u003c\/li\u003e\n\u003cli\u003eVirtual showrooms\u003c\/li\u003e\n\u003cli\u003eWebinars \u0026amp; video training\u003c\/li\u003e\n\u003cli\u003eRemote monitoring value-in-use\u003c\/li\u003e\n\u003cli\u003eCRM-driven lead nurture\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConferences \u0026amp; KOL networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePresence at specialty congresses and workshops (attending events with 5,000–20,000 specialists) and KOL partnerships provide peer-validated clinical efficacy, supporting adoption of Getinge systems; hands-on labs let clinicians evaluate device ergonomics and workflow integration, while thought-leadership sessions strengthen brand trust and influence procurement committees. Getinge reported 2024 net sales of SEK 38.5 billion.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eChannels: Conferences \u0026amp; KOL networks\u003c\/li\u003e\n\u003cli\u003eKOLs: clinical validation drives adoption\u003c\/li\u003e\n\u003cli\u003eHands-on labs: ergonomics + workflow testing\u003c\/li\u003e\n\u003cli\u003eThought leadership: builds trust with buyers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSolution selling to IDNs\/univ hospitals: \u003cstrong\u003eSEK 38.5bn\u003c\/strong\u003e, \u003cstrong\u003e~11,000\u003c\/strong\u003e staff, \u003cstrong\u003e3–5y\u003c\/strong\u003e service, uptime \u003cstrong\u003e\u0026gt;95%\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGetinge sells via direct account teams to IDNs\/university hospitals, supported by ~11,000 employees and SEK 38.5bn 2024 sales, using solution selling across ICU\/OR\/CSSD with multi‑year (3–5y) service contracts. Local distributors cover 40+ markets with performance KPIs; public tenders\/GPOs (public procurement ~14% EU GDP; \u0026gt;90% US hospitals use GPOs) drive volume. Digital channels shorten cycles (85% B2B research); conferences\/KOLs validate clinical adoption; service uptime targets \u0026gt;95%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eChannel\u003c\/th\u003e\n\u003cth\u003eReach\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect account teams\u003c\/td\u003e\n\u003ctd\u003eIDNs, univ hospitals\u003c\/td\u003e\n\u003ctd\u003eSEK 38.5bn sales (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributors\u003c\/td\u003e\n\u003ctd\u003e40+ markets\u003c\/td\u003e\n\u003ctd\u003ePerformance KPIs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTenders \/ GPOs\u003c\/td\u003e\n\u003ctd\u003eNational\/global\u003c\/td\u003e\n\u003ctd\u003ePublic procurement ~14% EU GDP; \u0026gt;90% US hospitals use GPOs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital \u0026amp; events\u003c\/td\u003e\n\u003ctd\u003eGlobal\u003c\/td\u003e\n\u003ctd\u003e85% B2B research; KOLs, uptime \u0026gt;95%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Segments\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcute care hospitals \u0026amp; IDNs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAcute care hospitals and IDNs are the primary buyers of ICU ventilation, OR solutions and CSSD equipment. As of 2024 there are roughly 6,000 US acute hospitals and about 1,300 health systems, driving large-volume tenders and committee-led procurement. Key value drivers are clinical outcomes, equipment uptime and total cost of ownership; buyers favor standardized, interoperable platforms to simplify integration and servicing.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCardiovascular centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCardiovascular centers require integrated perfusion systems and OR connectivity for complex cardiac cases, supporting safety, precision and streamlined workflow. With \u0026gt;1.5 million cardiac surgeries globally in 2024, purchases are high-value and high-complexity, prioritizing lifecycle costs. Strong demand exists for comprehensive training and rapid service responsiveness to minimize OR downtime and clinical risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAmbulatory surgery centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAmbulatory surgery centers (~6,300 in the US in 2024) prioritize compact OR and sterilization systems that enable fast turnover (benchmarks target \u0026lt;30-minute room turnover). Cost sensitivity and tight footprints drive preference for lower-capex, modular solutions with rapid installation measured in days and intuitive controls. Service contracts are sized to support lean staffing and predictable OPEX.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSterile processing departments (CSSD)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSterile processing departments (CSSD) demand validated sterilization, instrument-level traceability (ISO 17664, IEC 62353) and high throughput to meet Joint Commission and national audit requirements; integration with instrument-tracking systems reduces instrument search time and supports predictable service to avoid surgical delays.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eValidated sterilization: ISO 17664\u003c\/li\u003e\n\u003cli\u003eTraceability: instrument-level\u003c\/li\u003e\n\u003cli\u003eThroughput: uptime-focused\u003c\/li\u003e\n\u003cli\u003eCompliance: audit-ready\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLife science \u0026amp; biopharma facilities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eLife science and biopharma facilities require validated bioprocessing and lab sterilization equipment designed for GMP compliance and repeatable workflows; FDA and EMA GMP expectations remained enforced in 2024, stressing validation and data integrity. Scalability from R\u0026amp;D to commercial production shortens time-to-market, while integrated validation and ALCOA+ data integrity support are essential.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRequirement: GMP-compliant sterilization\u003c\/li\u003e\n\u003cli\u003ePriority: repeatability \u0026amp; scalability\u003c\/li\u003e\n\u003cli\u003eNeed: validation \u0026amp; ALCOA+ data integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospitals, cardiac centers and ASCs demand uptime, low TCO, modular ORs and GMP data integrity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePrimary customers: ~6,000 US acute hospitals and ~1,300 IDNs (2024) buying ICU ventilators, OR and CSSD platforms prioritizing uptime, outcomes and TCO. Cardiac centers (\u0026gt;1.5M global surgeries in 2024) buy high‑value perfusion\/OR integration. ASCs (~6,300 US in 2024) seek compact, low‑capex modular OR and sterilization. Biopharma needs GMP, validation and ALCOA+ data integrity.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003e2024 count\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcute\/IDN\u003c\/td\u003e\n\u003ctd\u003e6,000 \/ 1,300\u003c\/td\u003e\n\u003ctd\u003eUptime, TCO\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCardiac\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;1.5M surgeries\u003c\/td\u003e\n\u003ctd\u003eLifecycle cost\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eASC\u003c\/td\u003e\n\u003ctd\u003e6,300 (US)\u003c\/td\u003e\n\u003ctd\u003eTurnover time\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiopharma\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003eGMP, validation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eost Structure\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMaterials \u0026amp; manufacturing costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMaterials and manufacturing drive COGS at Getinge, with metals, electronics, software licensing and clean-room assembly concentrating cost; in 2024 gross margin ran around 48% while direct COGS components accounted for roughly half of product costs. Facility overhead for specialized testing and validation adds fixed costs that pressure margins; yield loss, scrap and warranty provisions (~0.7% of sales in 2024) erode profitability, and supplier performance causes cost variances of about 2–3%. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eR\u0026amp;D and clinical evidence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eR\u0026amp;D and clinical evidence costs center on engineering talent, prototypes, and verification\/validation, with Getinge investing SEK 1.9 billion in R\u0026amp;D in 2024 (~6% of revenue), funding prototype iterations and test labs. Clinical studies and usability testing incurred high trial and regulatory site costs, often hundreds of millions SEK per program. Ongoing software development and cybersecurity upkeep add recurrent operational spend, while IP protection and certification fees create steady legal and conformity costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory \u0026amp; quality compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRegulatory and quality compliance drives sustained spend on audit readiness, documentation and PMS activities, aligning with Getinge’s global QMS across sites; Getinge reported net sales of SEK 27,687 million in 2023, underscoring scale of compliance investment. CAPA execution and field actions incur direct remediation and recall costs, while ongoing training and QMS maintenance require continuous headcount and system spend. Country-specific registrations and renewals add recurring local fees and dossier updates.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales, marketing \u0026amp; tendering\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSales, marketing and tendering at Getinge combine field sales, in-clinic demos and KOL programs to drive clinical adoption; bid preparation includes tenders, performance bonds and clinical trials support, while conferences, education and digital campaigns sustain lead generation and brand trust; channel incentives and commissions align distributor performance and margin management.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eField sales, demos, KOLs\u003c\/li\u003e\n\u003cli\u003eBids, bonds, trials\u003c\/li\u003e\n\u003cli\u003eConferences, education, digital\u003c\/li\u003e\n\u003cli\u003eChannel incentives \u0026amp; commissions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eService \u0026amp; logistics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eService \u0026amp; logistics costs cover installations, calibrations and spare parts inventory, tying up working capital and driving aftermarket margins; in 2024 Getinge reported services and consumables at about 30% of net sales. Technician labor and ongoing training programs are key recurring OPEX; remote monitoring platforms and diagnostic tools add SaaS and hardware amortization. Global shipping, warehousing and returns raise logistics and reverse‑logistics spend, especially for capital equipment.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eInstallations\/calibrations: stocked SKUs, capital tie-up\u003c\/li\u003e\n\u003cli\u003eTechnician labor \u0026amp; training: recurring OPEX\u003c\/li\u003e\n\u003cli\u003eRemote monitoring: SaaS\/hardware amortization\u003c\/li\u003e\n\u003cli\u003eShipping\/warehousing\/returns: forward \u0026amp; reverse logistics costs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMargins pressured: gross margin \u003cstrong\u003e~48%\u003c\/strong\u003e, R\u0026amp;D \u003cstrong\u003eSEK 1.9bn\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMaterials, manufacturing and facility overhead drive COGS (gross margin ~48% in 2024) with warranty ~0.7% of sales and supplier variance ~2–3%. R\u0026amp;D was SEK 1.9bn in 2024 (~6% of revenue) covering prototypes, clinical trials and software upkeep. Services\/consumables ~30% of sales (2024) plus technician labor, logistics and SaaS amortization pressure margins.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin\u003c\/td\u003e\n\u003ctd\u003e~48%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003eSEK 1.9bn (~6%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWarranty\u003c\/td\u003e\n\u003ctd\u003e~0.7% sales\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eServices \u0026amp; consumables\u003c\/td\u003e\n\u003ctd\u003e~30% sales\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eevenue Streams\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCapital equipment sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCapital equipment sales generate one-time revenue from ICU, OR, CSSD and bioprocess systems, typically bundled with installation and initial training and supported by multi-year service contracts; procurement often occurs via tenders and multi-unit expansions. Replacement\/refresh cycles average 7–10 years, and deal sizes commonly reach mid-six to seven figures, with margins varying widely by configuration and region (roughly 10–30%).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsumables \u0026amp; disposables\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRecurring sales of filters, tubing, sterile packaging and reagents form a steady aftermarket tied directly to Getinge’s installed base and procedure volumes, supporting predictability and defensible margins. Getinge reported 2024 net sales of SEK 43.5 billion, with consumables underpinning recurring revenue. Regulatory and compliance needs sustain demand and reduce price elasticity, making renewal rates highly stable.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eService contracts \u0026amp; spare parts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eService contracts and spare parts cover preventive maintenance, extended warranties and repairs, with SLAs priced against defined uptime targets and response-time tiers to protect clinical availability.\u003c\/p\u003e\n\u003cp\u003eParts and labor can be billed per call or bundled into fixed-fee contracts to stabilize recurring revenue and improve gross margins.\u003c\/p\u003e\n\u003cp\u003eRemote support tiers—basic monitoring to advanced telemaintenance—add incremental value and reduce on-site intervention frequency while enabling higher-margin service offerings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSoftware, connectivity \u0026amp; analytics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSoftware, connectivity \u0026amp; analytics revenue at Getinge combines licenses and subscriptions for device software and integrations, contributing to recurring revenue as Getinge reported SEK 40.8 billion in 2024 net sales with services\/software showing double-digit growth in the service segment.\u003c\/p\u003e\n\u003cp\u003eFleet management, reporting and cybersecurity updates are sold as subscription tiers; interoperability modules (EMR\/LIS\/OR) and usage- or seat-based pricing expand wallet share and reduce churn.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLicenses\/subs: recurring ARR focus\u003c\/li\u003e\n\u003cli\u003eFleet \u0026amp; cybersecurity: tiered subscriptions\u003c\/li\u003e\n\u003cli\u003eInteroperability: EMR\/LIS\/OR modules\u003c\/li\u003e\n\u003cli\u003ePricing: usage- or seat-based models\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFinancing, rentals \u0026amp; managed services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpfinancing rentals and managed services deliver recurring revenue via leasing pay-per-use outcome-linked arrangements with cssd backed by performance commitments that standardize fleets preserve customer capital. multi-year contracts raise lifetime value getinge reported net sales of about sek billion in highlighting scale for service expansion.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLeasing and pay-per-use models\u003c\/li\u003e\n\u003cli\u003eOutcome-linked service contracts\u003c\/li\u003e\n\u003cli\u003eManaged CSSD\/OR with SLAs\u003c\/li\u003e\n\u003cli\u003eMulti-year deals boost LTV\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pfinancing\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCapital equipment drives one-time revenue; consumables, services \u0026amp; leasing expand recurring ARR\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCapital equipment (one-time, mid-6 to 7-figure deals, 7–10yr refresh, margins ~10–30%); consumables \u0026amp; reagents provide stable recurring revenue (Getinge 2024 net sales SEK 43.5bn) and service\/software show double-digit growth (services\/software supporting SEK 40.8bn). Leasing, pay-per-use and outcome-linked managed services expand ARR and LTV.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet sales\u003c\/td\u003e\n\u003ctd\u003eSEK 43.5bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eService\/software\u003c\/td\u003e\n\u003ctd\u003eSEK 40.8bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"PESTEL Analysis","offers":[{"title":"Default Title","offer_id":58097925488988,"sku":"getinge-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0938\/8127\/0620\/files\/getinge-business-model-canvas.png?v=1781795214","url":"https:\/\/pestel-analysis.com\/products\/getinge-business-model-canvas","provider":"PESTEL ANALYSIS","version":"1.0","type":"link"}